Works matching DE "TADALAFIL"


Results: 474
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension assocIated with chronic obstructive Lung Disease) trial

    Published in:
    Pulmonary Circulation, 2013, v. 3, n. 4, p. 889, doi. 10.1086/674759
    By:
    • Maron, Bradley A.;
    • Goldstein, Ronald H.;
    • Rounds, Sharon I.;
    • Shapiro, Shelley;
    • Jankowich, Matthew;
    • Garshick, Eric;
    • Moy, Marilyn L.;
    • Gagnon, David;
    • Choudhary, Gaurav
    Publication type:
    Article
    27
    28

    Correction.

    Published in:
    2020
    Publication type:
    Correction Notice
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    What's inside.

    Published in:
    Indian Journal of Urology, 2019, v. 35, n. 1, p. 4, doi. 10.4103/iju.IJU_370_18
    By:
    • Kumar, Rajeev
    Publication type:
    Article
    41
    42

    What's inside.

    Published in:
    Indian Journal of Urology, 2018, v. 34, n. 4, p. 239, doi. 10.4103/iju.IJU_294_18
    By:
    • Kumar, Santosh
    Publication type:
    Article
    43

    Hearing loss with phosphodiesterase-5 inhibitors.

    Published in:
    Laryngoscope, 2013, v. 123, n. 6, p. 1527, doi. 10.1002/lary.23865
    By:
    • Thakur, Jagdeep S.;
    • Thakur, Somesh;
    • Sharma, Dev R.;
    • Mohindroo, Narinder K.;
    • Thakur, Anamika;
    • Negi, Prakash C.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    FDA Actions.

    Published in:
    OB/GYN Clinical Alert, 2011, p. 2
    Publication type:
    Article